SE8600355L - Forfarande for framstellning av 4,4-dialkyl-2-azetidinoner - Google Patents

Forfarande for framstellning av 4,4-dialkyl-2-azetidinoner

Info

Publication number
SE8600355L
SE8600355L SE8600355A SE8600355A SE8600355L SE 8600355 L SE8600355 L SE 8600355L SE 8600355 A SE8600355 A SE 8600355A SE 8600355 A SE8600355 A SE 8600355A SE 8600355 L SE8600355 L SE 8600355L
Authority
SE
Sweden
Prior art keywords
azetidinones
dialkyl
preparing
procedure
amino
Prior art date
Application number
SE8600355A
Other languages
English (en)
Other versions
SE8600355D0 (sv
SE467824B (sv
Inventor
W A Slusarchyk
T Dejneka
W H Koster
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of SE8600355D0 publication Critical patent/SE8600355D0/sv
Publication of SE8600355L publication Critical patent/SE8600355L/sv
Publication of SE467824B publication Critical patent/SE467824B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/18—Salts thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
SE8600355A 1985-01-28 1986-01-27 Foerfarande foer framstaellning av 4,4-dialkyl-2-azetidinoner SE467824B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/695,775 US4638061A (en) 1985-01-28 1985-01-28 [3S(Z)]-2-[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy] acetic acid and intermediate

Publications (3)

Publication Number Publication Date
SE8600355D0 SE8600355D0 (sv) 1986-01-27
SE8600355L true SE8600355L (sv) 1986-07-29
SE467824B SE467824B (sv) 1992-09-21

Family

ID=24794413

Family Applications (3)

Application Number Title Priority Date Filing Date
SE8600355A SE467824B (sv) 1985-01-28 1986-01-27 Foerfarande foer framstaellning av 4,4-dialkyl-2-azetidinoner
SE9002338A SE468896B (sv) 1985-01-28 1990-07-03 Azetidinylderivat och foerfarande foer framstaellning daerav
SE9002337A SE502442C2 (sv) 1985-01-28 1990-07-03 (3S)-3-amino-2-oxo-4,4-dimetyl-1-azetidinylsulfat samt ett förfarande för framställning av föreningen

Family Applications After (2)

Application Number Title Priority Date Filing Date
SE9002338A SE468896B (sv) 1985-01-28 1990-07-03 Azetidinylderivat och foerfarande foer framstaellning daerav
SE9002337A SE502442C2 (sv) 1985-01-28 1990-07-03 (3S)-3-amino-2-oxo-4,4-dimetyl-1-azetidinylsulfat samt ett förfarande för framställning av föreningen

Country Status (35)

Country Link
US (1) US4638061A (sv)
JP (2) JPH0780840B2 (sv)
KR (1) KR900000675B1 (sv)
CN (1) CN1014894B (sv)
AR (1) AR242024A1 (sv)
AT (1) AT389511B (sv)
AU (1) AU588017B2 (sv)
BE (1) BE904121A (sv)
CA (2) CA1283924C (sv)
CH (3) CH670824A5 (sv)
CS (1) CS253740B2 (sv)
DD (3) DD241600A5 (sv)
DE (1) DE3602347A1 (sv)
DK (1) DK39486A (sv)
EG (1) EG17682A (sv)
ES (3) ES8706112A1 (sv)
FI (1) FI85022C (sv)
FR (1) FR2576596B1 (sv)
GB (2) GB2170201B (sv)
GR (1) GR860239B (sv)
HU (1) HU196367B (sv)
IE (2) IE59629B1 (sv)
IL (1) IL77661A (sv)
IT (1) IT1190604B (sv)
LU (1) LU86262A1 (sv)
NL (1) NL8600136A (sv)
NO (1) NO170014C (sv)
NZ (1) NZ214836A (sv)
PH (3) PH22425A (sv)
PL (3) PL257668A1 (sv)
PT (1) PT81914B (sv)
RO (1) RO93483B (sv)
SE (3) SE467824B (sv)
YU (2) YU45760B (sv)
ZA (1) ZA86302B (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751220A (en) * 1986-12-19 1988-06-14 E. R. Squibb & Sons, Inc. Crystalline salts of [3S(Z)]-2[[[1-(2-amino-4-thiazolyl)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy)-3-azetidinyl]amino]-2-oxoethylidene]-amino]oxy]acetic acid
US5143913A (en) * 1988-04-04 1992-09-01 E. R. Squibb & Sons, Inc. [3S(Z)]-3-[[(2-amino-4-thiazolyl)[[2-(hydroxyamino)-2-oxoethoxy]imino]acetyl]amino]-2,2-dimethyl-4-oxo-1-azetidinyl sulfate
JPH01290674A (ja) * 1988-04-04 1989-11-22 E R Squibb & Sons Inc アゼチジニル誘導体
US4973747A (en) * 1989-08-15 1990-11-27 E. R. Squibb & Sons, Inc. Process for preparing 3-hydroxy 2-keto acids
KR101403164B1 (ko) * 2005-12-07 2014-06-03 바실리어 파마슈티카 아게 베타-락타마아제 저해제 및 모노박탐 항생물질의 유용한조합
US10047077B2 (en) 2016-04-13 2018-08-14 Skyline Antiinfectives, Inc. Deuterated O-sulfated beta-lactam hydroxamic acids and deuterated N-sulfated beta-lactams

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4337197A (en) * 1980-10-31 1982-06-29 E. R. Squibb & Sons, Inc. O-sulfated β-lactam hydroxamic acids and intermediates
JPS58113174A (ja) * 1981-12-26 1983-07-05 Toyama Chem Co Ltd 新規なアゼチジン誘導体またはその塩類を含有する抗菌剤
JPS58194856A (ja) * 1982-05-10 1983-11-12 Yamanouchi Pharmaceut Co Ltd 新規２−アゼチジノン誘導体
JPS58206589A (ja) * 1982-05-26 1983-12-01 Yamanouchi Pharmaceut Co Ltd ２−アゼチジノン誘導体
US4565654A (en) * 1983-03-28 1986-01-21 University Of Notre Dame Du Lac N-Acyloxy monocyclic β-lactams

Also Published As

Publication number Publication date
HUT40407A (en) 1986-12-28
CH667872A5 (fr) 1988-11-15
YU45760B (sh) 1992-07-20
HU196367B (en) 1988-11-28
NZ214836A (en) 1988-10-28
SE502442C2 (sv) 1995-10-16
SE9002337L (sv) 1990-07-03
PT81914A (en) 1986-02-01
FI860247A0 (fi) 1986-01-20
SE8600355D0 (sv) 1986-01-27
AU5246086A (en) 1986-07-31
IE860205L (en) 1986-07-28
GR860239B (en) 1986-05-28
ES557057A0 (es) 1988-03-01
KR860005812A (ko) 1986-08-13
FR2576596B1 (fr) 1989-12-15
FI85022B (fi) 1991-11-15
US4638061A (en) 1987-01-20
CS253740B2 (en) 1987-12-17
KR900000675B1 (ko) 1990-02-02
DD241600A5 (de) 1986-12-17
DD248592A5 (de) 1987-08-12
AT389511B (de) 1989-12-27
JPS61176563A (ja) 1986-08-08
SE9002338D0 (sv) 1990-07-03
ZA86302B (en) 1986-08-27
IE59629B1 (en) 1994-03-09
JPH0853404A (ja) 1996-02-27
PH22425A (en) 1988-09-12
NO860273L (no) 1986-07-29
PH23084A (en) 1989-04-10
CA1283924C (en) 1991-05-07
GB8800425D0 (en) 1988-02-10
AU588017B2 (en) 1989-09-07
ES8800897A1 (es) 1987-12-01
FI860247L (fi) 1986-07-29
YU5886A (en) 1988-02-29
ES551252A0 (es) 1987-06-01
YU167087A (en) 1988-04-30
PL262318A1 (en) 1987-09-07
GB2198133B (en) 1989-01-11
DD248584A5 (de) 1987-08-12
DK39486A (da) 1986-07-29
CH670825A5 (sv) 1989-07-14
PL257668A1 (en) 1987-03-09
IT1190604B (it) 1988-02-16
LU86262A1 (fr) 1986-08-04
SE9002337D0 (sv) 1990-07-03
ES557056A0 (es) 1987-12-01
NO170014C (no) 1992-09-02
NO170014B (no) 1992-05-25
IE930750L (en) 1986-07-28
FI85022C (sv) 1992-02-25
EG17682A (en) 1990-10-30
FR2576596A1 (fr) 1986-08-01
SE468896B (sv) 1993-04-05
RO93483A (ro) 1987-12-31
IT8619206A0 (it) 1986-01-28
BE904121A (fr) 1986-05-15
DE3602347A1 (de) 1986-07-31
PH23093A (en) 1989-04-10
ES8801917A1 (es) 1988-03-01
NL8600136A (nl) 1986-08-18
GB2170201A (en) 1986-07-30
SE9002338L (sv) 1990-07-03
JPH0780840B2 (ja) 1995-08-30
CN86100736A (zh) 1986-10-22
PT81914B (pt) 1987-11-30
CH670824A5 (sv) 1989-07-14
GB2170201B (en) 1989-01-11
DK39486D0 (da) 1986-01-27
PL149156B1 (en) 1990-01-31
PL262317A1 (en) 1987-09-07
RO93483B (ro) 1988-01-01
ATA20386A (de) 1989-05-15
AR242024A1 (es) 1993-02-26
CN1014894B (zh) 1991-11-27
IL77661A (en) 1989-06-30
GB2198133A (en) 1988-06-08
SE467824B (sv) 1992-09-21
ES8706112A1 (es) 1987-06-01
CA1279322C (en) 1991-01-22

Similar Documents

Publication Publication Date Title
AU560179B2 (en) Hypoglycemic thiazolidinedione derivatives
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
SE8600355D0 (sv) Forfarande for framstellning av 4,4-dialkyl-2-azetidinoner
FI853648A7 (sv) Förfarande för framställning av farmaceutiskt aktiva 4,5-dihydro-4-okso-2-/(2-trans-fenylcyklopropyamino/-3-furankarboxylsyror och derivat därav.
FI882002L (sv) Förfarande för framställning av terapeutiskt aktiva fenylpiperidinderivat
FI900145L (sv) Förfarande för framställning av farmaceutiskt användbara 1,1-dioxo-cefem-4-karbotiolsyraderivat
NL193639B (nl) Farmaceutisch aanvaardbare zouten van [3S(Z)]-2[[[1-(2-aminothiazolyl-4)-2-[[2,2-dimethyl-4-oxo-1-(sulfooxy) -3-azetidinyl]amino]-2-oxoethylideen]amino]-oxy]azijnzuur.
AU4545289A (en) 2-azabicyclo(2.2.1)hept-5-ene-2-acetic acid, derivatives thereof and related compounds, process for the preparation of said compounds and the use of said compounds for the manufacture of n-phosphonomethylglycine
FI93216C (sv) Analogiförfarande för framställning av terapeutiskt användbara 1,3-dioxanalkensyraderivat
DE3374008D1 (en) Process for the preparation of azetidine sulfonic acids
IL83495A0 (en) Oxirane pseudooligosaccharides,a process for their preparation,and pharmaceutical preparations containing them
FI894813A0 (sv) Förfarande för framställning av terapeutiskt aktiva 2-metoxikarbonylsubstituerade N,N'-di(trimetoxibensoyl)piperazinderivat
AU3620089A (en) New process for the preparation of n-(23-vinblastinoyl) derivatives of 1-amino-methyl-phosphonic acid
GR3018126T3 (en) 4-[(Thiophene-2-carbonyl)oxy]pyrrolidine-2-carboxylic acid, its preparation and its use as anti-inflammatory and anti-dystrophic agent.
HU908316D0 (en) Process for the production of medical preparations containing new amino-acid derivatives with medicative effect
NO943458D0 (no) Fremgangsmåte for fremstilling av terapeutisk aktivt amphiregulin

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8600355-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8600355-5

Format of ref document f/p: F